Evidence map›Paper›PMID 40861712›Full record

ArticleCureus2025

Nodal Involvement in Prostate Cancer: Implications for Diagnosis and Treatment.

Mohamed Salem, James Robenson

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohamed SalemDepartment of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, USA.
James RobensonDepartment of Cardiothoracic Surgery, AdventHealth Orlando, Orlando, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognosis and treatment of prostate cancer are highly dependent on the involvement of nodes. The present study aimed to investigate the association between nodal involvement and various clinical parameters such as age, stage, grade, X-ray results, and acid phosphatase levels, respectively. MATERIALS AND

methodsFifty-three patients' datasets were analyzed, which included variables like age, stage, grade, X-ray results, and acid phosphatase levels. To find out relationships or differences among patients having and not having nodal involvement, descriptive statistics, correlation analyses, and comparative analyses were used. This study used pre-collected data from the Rdatasets repository, where the data were anonymized prior to analysis in order to protect the confidentiality of patient information. Ethical standards and regulations were adhered to while performing all procedures.

resultsAnalysis indicated that 20 patients (37.7%) had nodal involvement in their tumors. Those with nodal involvement exhibited increased grades and stages of malignancy, as well as more frequent positive X-ray findings (e.g., acid phosphatase elevation), compared to patients without nodal involvement. However, the statistical significance of these differences could not be confirmed due to the absence of corresponding p-values or confidence intervals. These diagnostic markers often occur together; hence, there is a strong positive correlation between X-ray results and acid phosphatase levels (r = 0.80). Additionally, older patients showed lower chances of getting positive X-rays as well as acid phosphate outcomes, as evidenced by these moderate negative correlations (r = -0.37; r = -0.52, respectively).

conclusionNodal involvement in prostate cancer is associated with significantly higher cancer stages as well as grades alongside positive diagnostic markers, including X-ray results or even acid phosphatase levels. Thus, it is very important for comprehensive diagnostic evaluations to be done when managing prostate cancer cases because this issue calls for attention, according to our findings. Further research is needed to elucidate the underlying biological mechanisms responsible for the observed associations, particularly the role of nodal involvement in malignancy progression. Future studies should also aim to validate these findings in larger, multiethnic populations and explore longitudinal outcomes to better understand causality and clinical implications.

Indexed as

cancer stagingdiagnostic markersnodal involvementprostate cancertreatment strategies

Identifiers

PMID40861712
PMCPMC12372542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.